Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
Veru Inc. announced participation in the 2026 Cantor Global Healthcare Conference where CEO Mitchell Steiner will discuss ongoing clinical developments. The company focuses on late-stage biopharmaceutical programs, notably the Phase 2b PLATEAU trial evaluating enobosarm in combination with GLP-1 receptor agonists for improved weight reduction and m…